Showing 2,181 - 2,200 results of 101,133 for search '(( 5 wt decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.68s Refine Results
  1. 2181
  2. 2182
  3. 2183
  4. 2184

    LA decreases infarct size in rats subjected to I/R injury. by Chao Deng (329151)

    Published 2013
    “…<p>Representative illustrations of infarct size as stained by Evans Blue and TTC (a). LA decreased infarct size compared with I/R+V group and wortmannin pretreated group (b). …”
  5. 2185

    Analysis of DRD1 and DRD2 signalling upon dopamine treatment in SH-SY5Y-DRD1 or -DRD2 stable lines untransduced or transduced by WT or G2019S LRRK2. by Mauro Rassu (4068670)

    Published 2017
    “…<p><b>(A)</b> Cells stably expressing FLAG-tagged DRD1 were transduced by the different LRRK2 isoforms. 48h after transduction the cell were treated for different time points (15', 30', 60') by dopamine. …”
  6. 2186

    LA decreases cardiomyocyte apoptosis in rats subjected to MI/R injury. by Chao Deng (329151)

    Published 2013
    “…<p>Representative photomicrograph showed that TUNEL-positive cardiomyocytes were more frequently observed in I/R+V group and the wortmannin-pretreated group compared with the LA group (a). …”
  7. 2187
  8. 2188

    General motor activity of WT and <i>rSey<sup>2</sup>/+</i> rats in an open-field test. by Toshiko Umeda (358618)

    Published 2013
    “…<i>rSey<sup>2</sup>/+</i> rats exhibited decrease in the number of rearing compared to WT (genotype: F(1) = 6.54, P<0.02; time: F(5) = 17.13, P<0.001; genotype × time: F(5) = 3.74, P<0.005; <b>D</b>), although time spent in locomotion (<b>A</b>), distance of locomotion (<b>B</b>), and speed of movement (<b>C</b>) were not significantly changed. …”
  9. 2189
  10. 2190

    <i>skn-1b</i> is not required for WT or <i>daf-2</i> longevity A-F) Survival of WT and <i>skn-1b</i> mutants in the absence and presence of <i>daf-2</i> mutation. by Nikolaos Tataridas-Pallas (10231350)

    Published 2021
    “…We conclude that <i>skn-1b</i> does not contribute to <i>daf-2</i> longevity. In a total of 15 trials (13 on OP50, 2 on HT115) bacteria we observed a slight decrease in <i>skn-1b</i> longevity compared to WT in 4 trials (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s004" target="_blank">S4</a> and <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s005" target="_blank">S5</a> Tables). …”
  11. 2191
  12. 2192
  13. 2193
  14. 2194
  15. 2195

    Hepatic irradiation decreases the proportion of DX5<sup>–</sup>TRAIL<sup>+</sup> lrNK cells for up to two months. by Ryosuke Nakano (4557097)

    Published 2018
    “…<p>(A) The liver and splenic lymphocytes were stained with anti-NK1.1, anti-TCRβ, and PI. …”
  16. 2196

    Responsiveness of WT and transgenic mice to two stage carcinogenesis protocol (DMBA/TPA). by Jian Fu (41067)

    Published 2010
    “…(B) SCC/papilloma ratio indicating a sharp decrease in K5-VILIP-1 with respect to WT mice (p<0.01). …”
  17. 2197
  18. 2198

    Decreased splicing efficiency in DENV infected cells. by Federico A. De Maio (3091644)

    Published 2016
    “…<p>(A) Schematic representation of splicing analysis. …”
  19. 2199
  20. 2200

    Development of lymphangioma in PAI-1 WT or PAI-1<sup>−/−</sup> mice. by Françoise Bruyère (4734)

    Published 2013
    “…<p>A macroscopic decrease of lymphangioma is observed in PAI-1<sup>−/−</sup> as compared to WT (A). …”